Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by Ingiboy on Feb 19, 2024 11:32am

Why ?

Not sure why Andrew and Jamie would have bought so many shares (27,400,000) knowing the Shiseido Arbitration was pending.  Did they factor in the scenario where Replicel lost the Arbitration which turned out to be the case ?  It would appear they were disappointed in the judgement but did have a contingency plan.  What is the plan ?   After this long wait I am speculating it is a privatization.
Will there be a buyout of those wanting to not participate ?
Comment by BellEnd on Feb 20, 2024 10:13am
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Feb 21, 2024 11:44am
I would love to see the company sold outright but that doesn't look like that is what is going to happen. With this lengthy delay a sale of the company would have been announced by now.  What would they be buying ?   An unapproved dermal injection device.  Three stem cell technologies (RCH-01, RCT-01  RCS-01)  which are far from commercialization.   I don't ...more  
Comment by bluemoons20 on Feb 23, 2024 12:14pm
AT the end of the day it does not matter if  people do not want to participate.  Either  relative to privatization or a sale!!  If  the insiders have enough votes  , thats what happens and everyone gets paid the same money per share. A buy out would likely be better as all shareholders get the same  price.  If however, they take it private , then   ...more  
Comment by Ingiboy on Feb 25, 2024 11:27am
Bluemoons20 in your post regarding Privatization you are assuming the "minor shareholders may get bought out at a set price".  I don't fully understand the Privatization process.  Is there a chance the insiders who hold a large majority of the shares take the company private and don't offer a buyout of the minor shareholders ?  
Comment by bluemoons20 on Feb 25, 2024 4:33pm
I  do not think that is possible  but do stand to be corrected.  If the company is  now  private  rather than publicly traded  then  there would be no protection for  the  'minor' shareholders , the   majors  could  squeeze them  out by  maybe doing a  reverse split  )rollback)  of  shares.   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities